Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Real-time Estimate Cboe BZX Other stock markets 11:24:31 2024-12-06 am EST			5-day change	1st Jan Change
529.26 ^USD	+1.61%		+0.04%	-0.18%

Dec. 04	Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	MT
Dec. 04	Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	CI

Presentation Operator MessageOperator (Operator)Good morning...

This article is reserved for subscribers

To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	Dec. 04	MT
Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	Dec. 04	CI
Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675	Dec. 02	MT
CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target	Nov. 21	MT
Thermo Fisher Scientific Inc. Presents at 6th Annual Wolfe Research Healthcare Conference 2024, Nov-19-2024 08:00 AM	Nov. 19
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback	Nov. 15	MT
Thermo Fisher Board Approves New $4 Billion Stock Buyback	Nov. 15	DJ
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 15	CI
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares.	Nov. 15	CI
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million.	Nov. 14	CI
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	Nov. 14	CI
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test	Nov. 12	MT
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	Nov. 12	CI
Quidelortho Corporation Announces Executive Changes	Nov. 08	CI
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific	Nov. 06	CI
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 01	CI
Thermo Fisher Scientific Insider Sold Shares Worth $11,049,123, According to a Recent SEC Filing	Oct. 30	MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,120,320, According to a Recent SEC Filing	Oct. 29	MT
Devyser Enters Collaboration to Secure US Approval for Kidney Transplant Monitoring Test	Oct. 29	MT
Devyser aims to secure FDA approval for monitoring product	Oct. 29	FW
Devyser Enters into Agreement with Thermo Fisher Scientific to Collaborate on Obtaining U.S. Food and Drug Administration Approval for One Lambda? Devyser Accept Cfdna	Oct. 29	CI
ARC Independent Upgrades Thermo Fisher Scientific to Buy From Hold, $620 Price Target	Oct. 28	MT
Stephens Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating	Oct. 25	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $645 From $680	Oct. 25	MT
Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating	Oct. 24	MT